Findings were independently validated, including primary HCC tissue and functional in vitro studies, confirming potentially actionable candidates during hepatocarcinogenesis (RRM2, GMPS, BCAT1, PYCR2, and NEU1) that might be useful for the design of personalized chemopreventive strategies in the future. This evidence concerns the gene NEU1 and hepatocellular carcinoma.